Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-955-2 | CAS number: 91771-62-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Cyperus scariosus, Cyperaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6th February 2018-22nd March 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Cyperus scariosus, ext.
- EC Number:
- 294-955-2
- EC Name:
- Cyperus scariosus, ext.
- Cas Number:
- 91771-62-9
- IUPAC Name:
- Cyperus scariosus, ext.
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Batch Manufactured and supplied by
Jagat Aroma Oils Distillery,
Kannauj-209725,
Uttar Pradesh, India
Test Item : CYPRIOL (Cyperus Scariosus ext. Oil)
CAS No. : 91771-62-9 / 68916-60-9
Chemical Name (IUPAC)
Not applicable
Physical Appearance : Amber colored or Light Brown Liquid
Purity as per Certificate of Analysis: 100% Natural
Batch No. : Lot # 11/CYP/2016
Manufactured Date : November 2016
Retest Date : October 2018
Recommended Storage Condition: Ambient (+15 to +25°C)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: In-Vivo Biosciences, Kodigehalli Village, Magadi Road, Bangalore, Code-29, Karnataka State
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 9 to 11 weeks
- Weight at study initiation: 189.5-197.8g
- Fasting period before study: 16-18 hours
- Housing: Rats were housed individually in standard polysulfone cages
(Size: approximately L 425 x B 266 x H 185 mm), with stainless steel top grill having facilities for pelleted food and drinking water in polycarbonate bottle. Additionally, polycarbonate rat huts were placed inside the cage as an enrichment object and were changed along with the cage once a week.
Bedding: steam sterilized corn cob was used and changed once a week along with the cage.
- Diet (e.g. ad libitum): yes. Hypro Rat & Mice pellet feed, manufactured by Krishna Valley Agro Tech LLP, MIDC Kupwad block, Sangli, Maharashtra, was provided to animals.
- Water (e.g. ad libitum): yes. Deep bore-well water passed through activated charcoal filter and exposed to UV rays in Aquaguard on-line water filter-cum-purifier manufactured by Eureka Forbes Ltd, Mumbai 400 001, India, was provided to animals in polycarbonate bottles with stainless steel sipper tubes.
- Acclimation period: After physical examination for good health and suitability for experiment, the animals were acclimatized for six, eight, ten and twelve days before treatment G1-FTS, G1-STS, G2-FTS and G2-STS respectively. Animals were observed once daily during acclimatization period. Females were nulliparous and non-pregnant.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24 °C
- Humidity (%): 64 to 67 %
- Air changes (per hr): 13.2 to 14.0 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark cycle.
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The undiluted test item as supplied by the sponsor was administered as a single oral gavage to the fasted (16 to 18 hours) access to water was not interrupted. Each animal was administered the test item orally by gavage using disposable plastic syringe attached with metal feeding cannula. Food was offered about 3 to 4 hours after dosing. Water was not withheld
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: There was no acute oral toxicological information is available for the test item Cyperus Scariosus. Hence, the study was initiated with the starting dose of 300 mg/kg body weight. Hence the test was started as per Annex 2c of the OECD 423 test guideline. The starting dose was 300 mg/kg body weight (G1 FTS). - Doses:
- 300 & 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- Group Dose
(mg/kg) No. of
Rats Sex Rat numbers
From To
G1 (FTS) 300 3 Female Rm8031 Rm8033
G1 (STS) 300 3 Female Rm8034 Rm8036
G2 (FTS) 2000 3 Female Rm8037 Rm8039
G2 (STS) 2000 3 Female Rm8040 Rm8042
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- G1 - [300 mg/kg body weight – (FTS and STS)]: There were no pre-terminal deaths.
G2 - [2000 mg/kg body weight - (FTS and STS)]: There were no pre-terminal deaths. - Clinical signs:
- other: G1 - [300 mg/kg body weight – (FTS and STS)]: There were no clinical signs. G2 - [2000 mg/kg body weight - (FTS and STS)]: There were no clinical signs.
- Gross pathology:
- No abnormalities were detected at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of the present study, the test item, CYPRIOL (Cyperus Scariosus ext. Oil) has oral LD50 in the range of 2000 to 5000 mg/kg. The test item does not meet the criteria for classification per Regulation (EC) No 1272/2008.
- Executive summary:
The acute oral toxicity study with CYPRIOL (Cyperus Scariosus ext. Oil) in Wistar rats was conducted to assess the toxicological profile of the test item. The undiluted test item was administered as a single oral gavage to overnight fasted (16 to 17 hours) three female rats (G1-FTS) at a dose volume of 0.31 mL/kg body weight to attain the dose of 300 mg/kg body weight (G1-FTS). There were no clinical signs and pre-terminal deaths.
Based on the scheme - Annex 2c of the guideline OECD 423, three additional female rats were tested at the same dose of 300 mg/kg body weight (G1-STS). There were no clinical signs and pre-terminal deaths. Based on the scheme - Annex 2c of the guideline OECD 423, three female rats were tested at the next higher dose of 2000 mg/kg body weight and at the dose volume of 2.06 mL/kg body weight (G2-FTS). There were no clinical signs and pre-terminal deaths. Based on the scheme - Annex 2c of the guideline OECD 423, additional three female rats were tested at the same dose of 2000 mg/kg body weight (G2-STS). There were no clinical signs and pre-terminal deaths. Based on the scheme - Annex 2c of the guideline OECD 423, the dose was stopped.
The rats were observed for mortality and clinical signs for 14 days post treatment. Body weights were recorded prior to dosing on day 1 and again on days 8 and 15. Necropsy was performed for all the survived rats at terminal sacrifice. There were no clinical signs and mortality during the experiment period. All rats gained weight during experimental period. The rats were subjected to necropsy at termination and there were no abnormalities detected at necropsy.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.